Svenska
Boston
An independent LDT provider
Home
Press releases
Reports & Presentations
Stock information
Home
Stock information
Learn more
The Share
PDMR transactions
Ownership structure
Governance
Home
Governance
Learn more
General meetings
Board of Directors
Management team
Governance report
Nomination committee
External auditors
Remuneration committee
Internal control
Articles of association
Sustainability Report
Prospectuses
Home
Prospectuses
Learn more
Listing transfer (2018)
Rights Issue (2016)
Listing (2015)
Calendar
IR Contact
Home
IR Contact
Learn more
Subscribe
Subscribe
English
Svenska
Press releases
Show
All
Regulatory
R = Regulatory
January 31, 2025
Change in number of shares and votes in Immunovia AB (publ)
R
January 20, 2025
Immunovia AB announces outcome of exercise of warrants series TO 2
R
January 8, 2025
Immunovia AB (Publ) presents Nomination Committee
R
January 2, 2025
The exercise period for warrants of series TO 2 begins today
R
December 27, 2024
Immunovia announces determined exercise price for warrants series TO...
R
December 20, 2024
Immunovia discovery study published in top protein research journal
December 19, 2024
End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
December 18, 2024
Immunovia CEO and board members announce intention to fully exercise...
December 16, 2024
Immunovia to host a webcast with the opportunity to learn more about...
December 11, 2024
Immunovia announces financial calendar for financial year 2025/2026
December 9, 2024
Immunovia announces positive outcome and strong accuracy in the...
November 28, 2024
Immunovia to present at the Redeye Technology & Life Science Day
1
2
3
…
11
>
Home
Archives for jonas.kaas